In win for Abbey Labs, Elanco’s animal drug patent thrown out for lack of invention

Agriculture 2021-07-29 10:16 am By Miklos Bolza | Sydney

Please login to bookmark

IP Australia has refused to register a patent acquired by Elanco Australasia from Bayer covering a lice treatment, after amendments failed to address findings that the patent lacked an inventive step.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au